Skip to Content

Single-Cell RNA Sequencing in Stem Cell Research: Unraveling Heterogeneity and Fate Dynamics


Single-cell RNA sequencing (scRNA-seq) revolutionizes stem cell research by profiling transcriptomes at individual cell resolution, uncovering heterogeneity, rare subpopulations, and differentiation trajectories that bulk RNA-seq obscures. This technology maps dynamic gene expression during self-renewal, lineage commitment, and response to stimuli in embryonic, induced pluripotent, and adult stem cells.

openaccessjournals​

can be separated, for example, using flow cytometry to sort based on surface markers. In vitro differentiation and transplantation inform the lineage potential of single cells or sorted populations. These assays played a major role in establishing the hierarchical relationships between cell types. B, Molecular characterization of individual cells provides an additional method to study cellular heterogeneity. Computational analysis of these datasets indicates that cell types are more heterogeneous and that differentiation trajectories are more gradual than appreciated previously. B/NK indicates B/natural killer cell progenitor; CMP, common myeloid progenitor; DC, dendritic cell; ETP, early T-cell progenitor; GMP, granulocyte/macrophage progenitor; HSC, hematopoietic stem cell; MEP, megakaryocyte/erythroid progenitor; MLP, multilymphoid progenitor; MPP, multipotent progenitor; Prog, progenitor; RNA-seq, RNA sequencing. A, Hierarchy derived from Doulatov et al.4 B, K nearest neighbor graph derived from van Galen et al

Key Applications

scRNA-seq identifies pluripotency states and transitional cells in embryonic stem cells, revealing regulatory networks via clustering and pseudotime analysis. In adult stem cells like hematopoietic or mesenchymal types, it dissects niche-specific behaviors, aging effects, and therapeutic targets for regenerative medicine.

pmc.ncbi.nlm.nih​


Technical Advantages

Unlike bulk methods, scRNA-seq detects alternative splicing, non-coding RNAs, and cell-type markers, enabling disease modeling, drug screening, and personalized therapies through high-throughput profiling of patient-derived iPSCs.

academic.oup​

Challenges and Advances

Technical hurdles like dropout events and batch effects are addressed by optimized workflows for low-input stem cells, integrating with spatial or multi-omics data for comprehensive insights into stem cell fate decisions.

frontiersin​